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We report Africa’s first known graft-associated case of 
Creutzfeldt-Jakob disease (CJD), and compare it with other 
published cases. The patient presented 11 years postoperatively 
with ataxia, dysarthria, and cognitive impairment. Magnetic 
resonance imaging (MRI) (without diffusion weighting) and 
early electroencephalogram (EEG) were nonspecific, but 
triphasic waves appeared later, when cerebrospinal fluid 
(CSF) was positive for protein 14-3-3. Periodic synchronous 
discharges (PSDs) appeared 14 weeks before death. Delayed 
PSD may be a grave sign that forebodes death. 
   CJD belongs to a group of neurodegenerative disorders 
known as prion diseases. In these conditions an abnormal 
isoform of the prion protein (PrP) may develop: (i) sporadically; 
(ii) through genetic mutations in the prion protein gene 
(familial CJD); or (iii) through infection, as in new-variant and 
iatrogenic CJD. Cadaver-derived human dura mater grafts 
from infected but asymptomatic donors can cause CJD in the 
implanted host.
Case report
A 27-year-old South African man underwent correction of an 
Arnold-Chiari malformation and syringomyelia in 1991. The 
patient remained well until he presented on 8 March 2002 with 
a 12-week history of truncal ataxia and subjective cognitive 
impairment. Examination revealed cerebellar abnormalities 
only, with truncal ataxia and dysarthria prominent. Baseline 
investigations including a lumbar puncture and 3 MRIs 
(including contrast) were normal; diffusion-weighted MRI 
was unavailable at the time of presentation. An EEG revealed 
diffuse background slowing only. 
   A trial of empirical methylprednisolone, 500 mg daily 
for 5 days, proved ineffective and the patient continued to 
deteriorate. He developed severe cerebellar and upper motor 
neuron signs, diffuse myoclonus, and clinically evident signs 
of cognitive impairment. A second EEG showed background 
slowing and triphasic waves, suggesting CJD. 
   A third EEG on 11 April 2002 exhibited a typical CJD pattern 
with diffuse background slowing, combined theta and delta 
waves and PSDs. Cerebrospinal fluid was positive for protein 
14-3-3. It was only at this stage that we learnt the patient had 
received a commercially available lyophilised dura mater graft 
(Lyodura, B Braun Meslungen AG, Meslungen, Germany) 
during surgery for his Arnold-Chiari malformation. A 
presumptive diagnosis of dura graft-associated CJD was made. 
There was no family history of CJD.
   At clinical review on 12 May 2002 severe deterioration was 
noted, with complete anarthria, tremor, myoclonus, and severe 
ataxia. The patient progressed through akinetic mutism and 
coma to death on 23 July 2002.
   Autopsy demonstrated spongiform cerebral and cerebellar 
cortical degeneration. Histolopathological examination in Cape 
Town revealed patchy cortical vacuolation, neuronal loss, and 
astrocytosis, which was most intense in the deeper layers. The 
cerebellum exhibited severe granular cell loss and astrocytosis, 
with molecular layer avacuolar shrinkage and cellularity 
evident. Purkinje cells were preserved, and plaques were not 
seen with routine staining.  Cortical immunostaining by the 
Paris Reference Laboratory confirmed prion type I and the 
diagnosis of probable dural graft-associated CJD. 
Discussion
Our patient exhibited both typical and unusual features. Brown 
et al.1 reported presenting symptom frequencies in 5 CJD 
cases following infratentorial and cervical grafting as follows: 
cerebellar (N = 3); mental (N = 1); visual (N = 2). In a series of 
57 Japanese patients Hoshi et al.2 recorded presenting symptom 
incidences as follows: cerebellar 56.1%, memory disturbance 
68.4%, disorientation 56.1%, and visual/oculumotor 
disturbance 50.9%. Our patient fitted both patterns, as did 
his later development of myoclonus and akinetic mutism. In 
the series by Hoshi et al.2 66.0% developed myoclonus and 
56.0% akinetic mutism within 3 months of presentation. Our 
patient’s 11-year (132-month) latency accords with the Japanese 
experience (range 14 - 275 months, mean 125 months);3 the 
time from onset to death, 7.5 months, is at the lower end of the 
Japanese range (3 - 81 months).2
   The diagnosis was delayed by the late revelation of a grafting 
history, normal imaging, and the absence of diagnostic EEG 
changes. In the series by Hoshi et al.2 only 3 of 57 patients had 
normal imaging on presentation, while only 2 of 54 failed 
to show PSD on EEG; 1 of 54 exhibited PSD only on the day 
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and illness durations of 8 and 17 months respectively. An 
Austrian patient without PSD survived 5 months from onset.5 
Kimura et  al.6 reported a patient with imaging unchanged 
throughout his illness, who developed PSD just 2 days 
before death, 13 months after onset of symptoms. The case 
described by Takashima et al.,7 without PSD and with normal 
serial computed tomography (CT) scans, survived 17 months 
from onset. An American patient grafted with a Tutoplast 
patch survived 4 months from onset; imaging failed to assist 
diagnosis, while the EEG revealed only moderate to diffuse 
slowing.8 Interestingly, plaque formation was noteworthy in a 
number of these reports.5,6,8 
   Our case and the literature reports suggest that disease 
duration may be shorter in patients who do not show PSDs or 
in whom PSDs develop late. Subsets of graft-associated CJD 
may exist; this, together with host characteristics, might explain 
the differing clinical courses and disease phenotypes seen in 
graft-associated CJD.
Conclusion
Our report adds to the approximately 169 cases of dural 
graft-associated CJD cases.9 It supports the view that graft-
associated CJD patients are younger than sporadic CJD cases, 
and are more likely to present with cerebellar abnormalities. 
Brain imaging without diffusion weighting may not always 
contribute to the diagnosis. We note an interesting association 
between delayed or absent PSDs and short illness duration. 
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Lodox Statscan proves to be invaluable in forensic medicine
G J Knobel, G Flash, G F Bowie
The Statscan (Lodox Systems Pty (Ltd), Sandton, South Africa) 
is a low-dose, digital full-body X-ray machine designed 
specifically for use in hospital trauma units. The technology 
was developed by De Beers to be used in X-ray machines that 
could rapidly determine the location of stolen diamonds on 
workers using a low radiation dose.  The machine makes use 
of a thin fan-beam X-ray that is scanned down the length of the 
patient in 13 seconds.  A proprietary digital detector consisting 
of CCD cameras and fibreoptic tapers produces a full-body 
actual-size image of the patient, which is viewed on a dedicated 
21-inch digital viewing station.
   The Statscan is approved by the Food and Drug 
Administration in the USA and has received European Union 
certification for sale in Europe.
   The benefits of the Statscan to trauma radiology are its low 
dosage to patients and operators, ease of use and ability to 
provide a full-body image, and the speed of image acquisition.
   The Statscan was clinically evaluated at Groote Schuur 
Hospital’s Trauma Unit and is being evaluated for paediatric 
radiography at Red Cross Children’s Hospital.  Findings from 
both sites have been very positive, resulting in the sale and 
installation of 8 machines in the USA and 2 machines in Sudan.
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